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Abstract
Autism spectrum disorder (ASD) is a condition that consists of deficits in social
communication as well as restricted, repetitive interests or behaviors. Individuals with
ASD also often have comorbid psychiatric and medical disorders. One such concern is
high rates of seizures and epilepsy. Researchers have found that rates of seizures tend to
be higher in individuals with ASD who also have more impaired functioning. However,
few studies have examined how the presence of seizures is related to symptoms of ASD.
The current study aimed to expand the extant literature by investigating whether a history
of seizures is associated with ASD symptomology across different domains (i.e.,
Socialization/Nonverbal Communication, Restricted Interests/Repetitive Behaviors,
Communication), as measured by the BISCUIT-Part 1. Young children with atypical
development without a diagnosis of ASD or a history of seizures were found to have the
lowest endorsement of overall ASD symptomology as well as across subscales.
Individuals with seizures but without an ASD diagnosis had the second lowest scores,
followed by individuals with both ASD and seizures. The ASD without a history of
seizures group had the highest ASD symptomology scores. These results indicate that,
for atypically developing individuals without ASD, a history of seizures was related to
higher levels of autism symptomology. Conversely, for young children with ASD, a
history of seizures was related to lower endorsement of autism symptoms than those
without a history of seizures. These findings support the need for early identification of
both ASD and seizure disorders, as both diagnoses have significant implications for
treatment. Future directions for research are discussed.
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Introduction
Autism spectrum disorder (ASD) is a neurodevelopmental disorder that involves
impairments in social communication as well as restricted, repetitive behaviors, interests,
and activities (American Psychiatric Association, 2013; Tidmarsh & Volkmar, 2003).
Although prevalence rates of ASD have increased in recent years (Baio, 2014), little is
known regarding the etiology or underlying mechanisms of the disorder. Research on
neurological or physiological abnormalities related to ASD have been largely
inconclusive. Although the potential biological underpinnings are still under
investigation, researchers have suggested that the high prevalence of seizures and
epilepsy within the disorder may indicate neurological differences in individuals with
ASD (Bolton et al., 2011; Danielsson, Gillberg, Billstedt, Gillberg, & Olsson, 2005; Frye,
2016; Levisohn, 2007; Tuchman & Rapin, 2002).
Several factors have been found to be related to risk of seizures in ASD, including
intellectual functioning, gender (Amiet et al., 2008; Bolton et al., 2011), and autism
severity (Gabis, Pomeroy, & Andriola, 2005). However, some researchers have
suggested that cognitive functioning underlies all of these associations, as lower
intellectual functioning in ASD is often related to female gender (Danielsson et al.,
2005). As the mechanism behind the relationship between ASD and seizures is
unknown, further investigation of factors associated with the presence of seizures in ASD
may help researchers and clinicians to better understand their co-occurrence.
The aim of the present study is to further investigate differences in ASD symptom
severity in individuals with comorbid ASD and seizures. Groups based on ASD
diagnosis and a history of seizures were compared to further elucidate whether seizures
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and seizure disorders are associated with overall ASD symptom severity and/or specific
symptoms (i.e., communication, socialization/nonverbal communication, repetitive
behavior/restricted interests). Further, the current study aims to expand the extant
literature, which has focused primarily on children, adolescents, and adults, by
investigating these differences in a sample of infants and toddlers. This will serve to
further elucidate whether differences in symptomology are evident at a young age.
Autism Spectrum Disorder
History of ASD
The first reports of conditions comparable to ASD were described by Leo Kanner
in 1943. Kanner (1943) described the heterogeneity of symptom presentation in 11
children, and drew parallels across the following symptoms: failure to relate to others;
marked “autistic aloneness”; failure to change body posture in anticipation of being held;
differences in verbal abilities; superior memory; delayed echolalia; replication of
personal pronouns in speech without altering them to be grammatically correct;
hypersensitivity to loud noises and sudden movements; repetitive repetition of
verbalizations; need for maintenance of sameness; limited variety of spontaneous
activity; and ability to maintain interest in objects. Kanner further noted that the parents
of all of these children were intelligent and very few were “warmhearted”, and therefore
suggested that the desire for “aloneness” may be associated with parental characteristics.
He also highlighted the fact that these children seemed to have adequate or high cognitive
abilities. Finally, Kanner attributed the characteristic failure to relate to others to an
innate, biological deficit, describing them as “inborn autistic disturbances of affective
contact (Kanner, 1943).
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In a follow-up study published nearly 30 years later, Kanner revisited these 11
individuals and reported on their current status (Kanner, 1971). In childhood, the
participants were described as having relatively good overall health. Although large head
circumference and gross motor difficulties were noted in some, fine motor skills were not
found to be impaired. Two of the children developed epileptic seizures, one in childhood
and one in adulthood. In contrast to his original finding that the intellectual functioning
of these children seemed to be close to average, in adulthood four were found to have
extremely low IQ. In both the original and follow up study, Kanner sought to
differentiate autism from childhood schizophrenia. He stated that while there were some
similarities, symptoms across the two disorders differed in many ways (Kanner, 1971).
Kanner further cited the fact that schizophrenia usually emerges as a change in behavior,
while the symptoms reported in children with autism seem to have been present from
birth (Kanner, 1943).
This view was supported by Kanner’s contemporary, Michael Rutter, who
outlined additional differences between schizophrenia and autism. These distinctions
included sex ratio (i.e., schizophrenia has roughly equal prevalence rates in males and
females, while autism is much more common in males) as well as family socioeconomic
status (i.e., parents of children with autism tend to have higher intelligence and
socioeconomic status [SES] than the general population, while parents of individuals with
schizophrenia typically have average intelligence and SES). Additionally, a family
history of schizophrenia is considered a risk factor for developing schizophrenia, while
individuals with infantile autism rarely have a relative with schizophrenia. Rutter also
found that individuals with autism tend to have lower than normal IQ with discrepancies
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between domains, as visuo-spatial abilities tend to be high while verbal abilities are often
low. Hallucinations and delusions, which are characteristic of schizophrenia, are not
common in autism. Finally, Rutter maintained Kanner’s assertion that autism symptoms
are stable over the lifespan, while the severity of symptoms of schizophrenia may change
over time (Rutter, 1968). The distinction between autism and schizophrenia was central
in paving the way for autism to be recognized as a separate disorder.
While researchers consistently found support for discrepancies between autism
and schizophrenia, Rutter’s findings did differ from Kanner’s assertions in that he found
that children with autism had lower intellectual functioning than the general population
(Rutter & Schopler, 1987), which is consistent with current estimates of intellectual
disability in 70% of individuals with ASD (Mannion, Leader, & Healy, 2013; Matson &
Nebel-Schwalm, 2007; Newschaffer et al., 2007). However, children with autism
differed from individuals with intellectual disability in several ways. First, though both
groups share an increased prevalence rate of seizures, seizures tend to begin later
(typically in adolescence) for individuals with ASD. There are also differences regarding
co-occurring genetic disorders, as well as the previously mentioned sex difference, which
is not observed in individuals with intellectual disability (Rutter & Schopler, 1987).
Early research on autism therefore supported its distinction as a separate, unique disorder.
Diagnostic Criteria
Diagnostic criteria for ASD have changed significantly in recent years. ASD was
first recognized as a disorder in the American Psychiatric Association’s (APA)
Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III;
American Psychiatric Association, 1980), which included infantile autism, childhood-

4

onset pervasive developmental disorder (PDD), and atypical PDD. One of the primary
differentiations between these diagnoses was that infantile autism must have onset before
30 months of age, while childhood PDD may emerge between 30 months and 12 years.
Atypical PDD included those individuals who did not meet criteria for either of the other
two types, but had atypical developmental in several domains.
In the Diagnostic and Statistical Manual of Mental Disorders, Third EditionRevised (DSM-III-R; American Psychiatric Association, 1987), these subtypes were reclassified as Autistic Disorder and Pervasive Developmental Disorder- Not Otherwise
Specified (PDD-NOS). Although Autistic Disorder included a specifier if age at onset
was after 36 months, the general requirement was emergence during infancy or
childhood. The three general criteria for Autistic Disorder were impairments in social
interaction, impairment in verbal and nonverbal communication, and the presence of
restricted activities and interests. The criteria for PDD-NOS were similar to that for PDD
in DSM-III: impairment in development, but the individual did not meet full criteria for
Autistic Disorder.
The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition
(DSM-IV; American Psychiatric Association, 2000) represented a shift toward
classification based on severity. The categories of PDD in DSM-IV included Autistic
Disorder, Asperger’s disorder, Rett’s Disorder, Childhood Disintegrative Disorder, and
PDD-NOS. The criteria for Autistic Disorder and PDD-NOS were relatively similar to
the previous DSM version; however, the inclusion of Asperger’s disorder represented a
classification for individuals who had deficits in social interaction and exhibited
restricted, repetitive, and stereotyped behavior and/or interests, but without deficits in
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communication or language. Rett’s disorder and Childhood Disintegrative Disorder both
involved the loss of previously acquired skills, though the criteria for Rett’s included
more emphasis on psychomotor development and earlier regression (i.e., 5-48 months),
while Childhood Disintegrative Disorder involved typical development for at least the
first two years of life, followed by regression of expressive or receptive language, social
skills, adaptive behavior, bowel or bladder control, play skills, or motor skills. Childhood
Disintegrative Disorder also required impairments in at least two of the three areas of
impairment necessary for an autistic disorder diagnosis.
The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM5; (American Psychiatric Association, 2013) marked an important shift in both the
diagnostic criteria as well as the categories for autism. A key change was that the
separate disorders were combined into a singular disorder with different levels of
symptom severity. Autistic Disorder, Asperger’s Disorder, and PDD-NOS were merged
into one diagnostic category: autism spectrum disorder. Additionally, the social and
communication categories were combined into one domain of social communication and
social interaction. Childhood disintegrative disorder is no longer classified as separate
developmental disorder, and Rett disorder is now considered a neurologic disorder with a
known genetic cause; therefore, both are not included in the most recent version of the
DSM (Volkmar & Reichow, 2013).
The current criteria for a diagnosis of ASD include persistent impairments in
social communication/interactions across settings and restricted, repetitive patterns of
behavior, interests or activities. The diagnostic criteria also require that symptoms be
present early in childhood and that they impair or limit functioning. For the social
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communication and interaction category, impairments must be present in: 1) socialemotional reciprocity (e.g., impairments in initiation of social interaction, sharing of
interests or emotions; social imitation); 2) nonverbal communication that is relevant to
socialization (e.g., impairments in eye contact, understanding and using body language,
speech intonation/volume/rhythm; affect); 3) developing and sustaining relationships
(beyond those with caregivers; e.g., impairments in theory of mind, adjusting behavior
based on social context, imaginative play, interest in others). In regard to the restricted,
repetitive patterns of behavior, interests, or activities, at least two of the following four
criteria must be met: 1) stereotyped or repetitive speech, motor movements, or object use
(e.g., pedantic or formal language, echolalia, pronoun reversal, perseverative language,
stereotyped or repetitive movements or use of objects); 2) excessively sticking to
routines, patterns of behavior, or resistance to change (e.g., adherence to routine,
ritualized patterns of verbal and nonverbal behavior, resistance to change, rigid thinking);
3) exceedingly limited, fixated interests that are unusual in intensity or focus (e.g.,
narrow range of interests, attachment to unusual inanimate objects; preoccupations or
obsessions); 4) over-reactivity or under-reactivity to sensory stimuli or unusual sensory
interests (e.g., high tolerance to pain, interest or fascination with watching movement of
objects, such as spinning wheels or fans, licking or smelling objects; APA, 2013).
Although ASD is considered one singular disorder, it includes three levels of
symptom severity. ASD Level 1 specifies that the functional impairments related to the
disorder require support; Level 2 indicates that the deficits require substantial supports;
and Level 3 reflects that the impairments require very substantial support. Several
specifiers have also been included to denote comorbidities. These include: with or
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without accompanying intellectual impairment; with or without accompanying language
impairment; associated with a known medical or genetic condition or environmental
factor; associated with other neurodevelopmental, mental, or behavioral disorders; and
with catatonia (APA, 2013).
Many of the diagnostic items in the DSM-IV-TR communication category now
fall under social communication or restricted, repetitive behavior, interests, and activities.
Impairments in social communication and interaction must also be present in multiple
settings. Furthermore, while restricted, repetitive behaviors and interests (RRBIs) were
not a requirement for a diagnosis under DSM-IV, these behaviors are now a mandatory
criterion for ASD. Individuals who present with deficits in social communication but do
not have RRBIs instead typically qualify for Social (Pragmatic) Communication
Disorder. Additional changes include: abnormal sensory responses are now included;
symptoms do not have to manifest prior to age 3; dual diagnosis of comorbid conditions
(e.g., ADHD) are now permitted; and historical report of behavioral symptoms can be
included in the diagnostic process (APA, 2013).
Prevalence of ASD
Although autism was once considered to be a relatively uncommon disorder,
occurring in as few as 3 or 5 children out of 10,000, prevalence rates have risen in recent
years (Howlin, 2006). The most current estimated prevalence is approximately 1 in 68
children (Baio, 2014). Additionally, there is a well-established sex difference, as males
are four to five times more likely to have ASD than females (Baio, 2014; Howlin, 2006).
Some considerations that may account for recent increases in prevalence rates include an
increase in awareness, changes in diagnostic criteria, improved methodology of research
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studies, cultural influences, and improvements in assessment and diagnostic practice
(Fombonne, 2009; Matson & Kozlowski, 2011; Volkmar, Lord, Bailey, Schultz, & Klin,
2004). ASD can potentially be diagnosed as young as 18 months of age (Chawarska et
al., 2014); however, many children do not receive a diagnosis until later in childhood
(Shattuck et al., 2009).
Comorbid Conditions
Psychiatric comorbidities are common in individuals with ASD. Simonoff and
colleagues (2008) found that 70% of children with ASD had at least one comorbid
condition and 41% had two or more. Common comorbidities include anxiety disorder,
attention-deficit hyperactivity (ADHD) disorder, oppositional defiant disorder, and mood
disorders (Leyfer et al., 2006; Simonoff et al., 2008). Individuals with ASD also have
high rates of medical conditions, including gastrointestinal issues, sleep concerns
(Mannion et al., 2013; Mazurek et al., 2012; Mazurek & Petroski, 2015) and genetic
conditions such as tuberous sclerosis, Fragile X syndrome, and Angelman syndrome
(Moss & Howlin, 2009). Additionally, seizure disorders are a medical comorbidity that
have been widely studied within this population (Danielsson et al., 2005; Frye, 2016;
Jokiranta et al., 2014; Mannion et al., 2013; Saemundsen, Ludvigsson, Hilmarsdottir, &
Rafnsson, 2007). The identification and treatment of comorbid disorders in individuals
with ASD is crucial, as these conditions can often exacerbate impairments in functioning
(Mazurek, 2016).
Seizures
A seizure is a “transient occurrence of signs and/or symptoms due to abnormal
excessive or synchronous neuronal activity in the brain” (Fisher et al., 2005). Epilepsy is
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a disorder that involves a predisposition to epileptic seizures, and typically is defined as
recurrent seizures (Reilly & Gillberg, 2016). Epilepsy is a common neurological disorder
(Reilly & Gillberg, 2016) and Hesdorffer and colleague (2011) estimated that the lifetime
prevalence of epilepsy is 1 in 26 people. The results of several studies indicate that the
risk of developing epilepsy may be greater at a younger ages and decreases during
puberty and into adulthood (Camfield, Camfield, Gordon, Wirrell, & Dooley, 1996;
Danielsson et al., 2005).
Types of Seizures
There are several different types of seizures, all of which fall into two categories:
generalized or partial/focal (Reilly & Gillberg, 2016). Generalized seizures originate
within bilateral networks and the location and lateralization are not the same for all
seizures. This class of seizures includes tonic-clonic, absence, myoclonic, clonic, tonic,
and atonic seizures (Berg et al., 2010). Tonic-clonic seizures, also known as grand mal
seizures, affect the entire body and are characterized by convulsions that cause muscle
rigidity and contractions. Absence seizures often present as blank facial affect and
unresponsiveness, and are classified as either typical or atypical. Typical absence seizures
often have a short duration and include impaired consciousness. Atypical absence
seizures have a longer duration and often include tonic, clonic, or automatic movements
(Holmes, 1997). Tonic seizures are usually brief and involve increased muscle tone in
extensor muscles as the muscles contract and stiffen. Consciousness is also often
impaired. Clonic seizures cause muscles to spasm, which results in jerking muscle
motions, while myoclonic seizures are short jerks of a muscle or groups of muscles,
similar to the characteristic physical response to shock. Lastly, atonic seizures usually
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involve loss of muscle tone, which can result in the person falling or in the dropping of
the head or slumping of the body (McCandless, 2012). Consciousness is sometimes also
impaired, and myocolonic jerks often occur after the atonic episodes. This type of
seizure occurs most often in children (Holmes, 1997).
Focal or partial seizures originate in a localized region and are confined to
networks within one hemisphere of the brain (Berg et al., 2010). Focal seizures include
both simple and complex partial seizures. In a complex partial seizure, the individual
exhibits impaired consciousness, meaning that they may not be aware or responsive.
Simple partial seizures do not involve changes in consciousness, but may include some
sensory auras (e.g., auditory, olfactory, visual hallucinations; McCandless, 2012).
Etiology
Theories regarding the etiology of seizures and epilepsy have evolved over the
last several decades. The etiologic categorizations of epilepsy include idiopathic,
symptomatic, provoked, and according to some researchers, cryptogenic. Idiopathic
seizures are those that have or are thought to have a genetic origin, and therefore do not
have a specific neuroanatomical or pathological cause (Shorvon, 2011). The defining
characteristics of these seizures are age at onset, clinical and electrographic features, and
an assumed genetic susceptibility (Berg et al., 2010). Symptomatic epilepsy has an
underlying cause that is associated with anatomical or pathological abnormalities. This
includes genetic disorders that are associated with pathological changes (e.g., tuberous
sclerosis, West syndrome), as well as those that are acquired (e.g., head trauma, cerebral
tumors or infection, neurodegenerative conditions). Finally, cryptogenic epilepsy
involves seizures with an unknown or unidentified cause. Provoked epilepsy is a fourth
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category used by some researchers. Provoked epilepsy is linked to a specific
environmental or systemic factor that causes the seizures in the absence of anatomical or
pathological irregularities (e.g., toxin-induced, drug-induced, metabolic). These factors
can include genetic or acquired bases (Shorvon, 2011).
Berg and colleagues (2010) advised that the terms idiopathic, symptomatic, and
cryptogenic had become too interwoven with different meanings and connotations within
the field, which led to inconsistencies in their use. They therefore proposed the following
alternative terms: genetic, structural/metabolic, and unknown cause. Genetic causes
imply that the seizures are a direct result of either an identified or presumed genetic
mutation. Structural/metabolic cause implies that there is a specific cause other than a
genetic one that is directly related to the occurrence of seizures. These include structural
lesions and metabolic diseases that may impair metabolism or osmolality, or introduce
toxins (O’Brien, 1998). Lastly, unknown cause represents a neutral view that the
underlying mechanism is unknown and may be related to an unidentified genetic
correlate or another process that is not yet understood in relation to seizures (Berg et al.,
2010).
However, regardless of the terminology used to describe the potential cause of
seizures, an important consideration is that many cases of epilepsy have multiple causes.
Often both genetic and environmental influences impact the individual’s susceptibility to
seizures and to developing epilepsy. As one cause is often considered the predominant
mechanism, using categories of causation has clinical utility but should not obscure other
contributing factors.
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Assessment and Treatment
Seizures and epilepsy are typically identified and diagnosed through clinical
description and the use of electroencephalogram (EEG) to detect any abnormalities in
neurological activity (Manford, 2001). EEG patterns can identify epileptiform
dischargers and determine whether these abnormalities are epileptic or non-epileptic
paroxysmal attacks. Different types of seizures (e.g., clonic, tonic) often show discrete
EEG patterns, and this distinction can aid in accurate diagnosis (Noachtar & Rémi, 2009).
The treatment for seizures depends on the type of seizure as well as individual
characteristics. Provoked seizures, which are caused by an identifiable source, are treated
by addressing the specific anomaly that is thought to have triggered the seizure. Seizures
that are not provoked are often treated by anti-epileptic drugs (AED). Common
anticonvulsants include phenobarbital, valproate, carbamazepine, gabapentin, topiramate,
oxcarbazepine, clobazam, phenytoin, lamotrigine, levetiracetam, rufinamide, lacosamide,
and zonisamide (McCandless, 2012). The type of AED prescribed typically depends on
the type of seizure. For example, certain AEDs (i.e., valproate, lamotrigine, and
topiramate) are very effective in treating absence seizures, but others can cause
deterioration (i.e., carbamazepine, tiagabine; Noachtar & Rémi, 2009). Therefore,
accurate assessment and diagnosis is crucial for treatment decisions.
If multiple AEDs are not effective in controlling seizures, in some cases surgery is
implemented as the next step. Types of surgery include curative surgeries (i.e., resection
of a seizure focus) and palliative surgeries (e.g., corpus callosotomy). Vagus nerve
stimulation is also sometimes used to reduced seizure by implanting a vagus nerve
stimulator under the patient’s clavicle (Tarulli, 2016).
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The ketogenic diet has also been promoted as a treatment for drug-resistant
seizures. The ketogenic diet is high in fat, low in protein, and low in carbohydrates. This
alteration in the body’s sources of energy is designed to elicit biochemical changes in the
brain that are associated with starvation (Freeman et al., 1998). This biochemical
response causes the body to replace glucose as the brain’s source of energy with ketones
(Hartman, Gasior, Vining, & Rogawski, 2007). The results of several studies support the
use of the ketogenic diet to control medication-resistant seizures (Groesbeck, Bluml, &
Kossoff, 2006; Kinsman, Vining, Quaskey, Mellits, & Freeman, 1992; Neal et al., 2008).
Prognosis
The impact of seizures and epilepsy on individuals is far-reaching. Researchers
have found that individuals incur significant financial burden from seizure treatments.
Factors that contribute to the cost of treatment include doctor visits, AEDs, tests and
procedures, medical services and supplies. Other financial considerations related to
seizures are cost of social services, transport to and from treatment, specific medical
equipment, and absence from work of school (Baker, Nashef, & van Hout, 1997). More
frequent seizures have also been found to be related to lower quality of life, as individuals
with epilepsy encounter psychosocial difficulties such as higher rates of unemployment
or underemployment (Smeets, van Lierop, Vanhoutvin, Aldenkamp, & Nijhuis, 2007),
stigmatization, and lower self-fulfillment ratings (Baker et al., 1997). Epilepsy-related
mortality rates are also a concern, as mortality is more common in those who experience
more frequent seizures than those whose seizures are better controlled (Baker et al.,
1997).
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Seizures in Individuals with ASD
Researchers have suggested that ASD and epilepsy may share a molecular
developmental mechanism. The fact that some genetic disorders such as tuberous
sclerosis and Fragile X syndrome are associated with both ASD and epilepsy provides
some support for this theory (Brooks-Kayal, 2010; Reilly & Gillberg, 2016). One
suggested explanation is that genetic mutations or the effects of seizures at a young age
can impact synaptic plasticity and may influence the presence of both ASD and epilepsy
(Brooks-Kayal, 2010). Researchers have also proposed that deficiencies in GABergic
signaling may be an underlying mechanism (Kang & Barnes, 2012), though the research
on this association is limited. Taken together, these studies emphasize the need for
further research on the potential underpinning for atypical neurological activity and ASD.
Prevalence
Prevalence rates of seizures and seizure disorders are estimated to be higher in
individuals with ASD than in the general population (Jokiranta et al., 2014). Relatedly,
researchers have found that the frequency of ASD diagnoses are higher in individuals
with epilepsy than those without (Reilly et al., 2014; Saemundsen et al., 2007).
Researchers have estimated the prevalence rate of seizures in individuals with ASD to be
between 5-40% (Danielsson et al., 2005; Gabis et al., 2005; Hrdlicka et al., 2004;
Jokiranta et al., 2014; Viscidi et al., 2013). There is also evidence that prevalence may
increase with age (Viscidi et al., 2013), so the differences in these rates may be due to
sample characteristics of the studies, including age range, level of functioning, and
definition of history of seizures (e.g., one seizure vs. diagnosis of epilepsy; Ballaban-Gil
& Tuchman, 2000).
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In addition to seizures and epilepsy, researchers have also investigated rate of
epileptiform abnormalities in individuals with ASD. These findings indicate that in
addition to higher rates of seizures in individuals with ASD than in the general
population, the rates of epileptiform abnormalities are also higher (Hrdlicka et al., 2004;
Kawasaki, Yokota, Shinomiya, Shimizu, & Niwa, 1997). This has important
implications for the understanding of the underlying mechanism for abnormal
neurological activity in ASD.
Age at onset
Several researchers have investigated the average age at onset of seizures and
whether age is related to other factors, such as level of impairment. Bishop (1985) found
that, in a sample of children with Landau-Kleffner syndrome, earlier the age at onset had
worse language prognoses. O’Leary and colleagues (1981) reported consistent findings
that children with onset of seizures prior to 5 years of age demonstrated greater cognitive
impairments than those with later onset. Similar results were reported based on a
comparison of age of onset prior to 2 years of age versus later in life (Vasconcellos et al.,
2001), and there is also evidence that the relationship between age at onset and cognitive
impairment is strongest early in life and decreases with age (Berg, Zelko, Levy, & Testa,
2012). However, contradictory findings indicate that age of onset may not be
significantly related to intellectual (Ellenberg, Hirtz, & Nelson, 1984) or adaptive
functioning (Berg et al. 2004).
As previously mentioned, Rutter and Schopler (1987) suggested that seizures
emerge later in individuals with ASD than those with ID, and typically occur in
adolescence. In a retrospective study conducted by Hara and colleagues (2007), the
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authors concluded the mean age at onset was 14 years, with a range of 8 to 26 years.
Similarly, Bolton and colleagues (2011) found that the average age of emergence was
13.3 years, and the majority of seizures began after age 10. Researchers have suggested
that the tendency for seizures to emerge in adolescence in individuals with ASD is
associated with age-related neurological development (Bolton et al., 2011).
However, Mouridsen and colleagues (1999) and Danielsson and colleagues
(2005) reported younger ages as onset of 8.1 year and 7.5 years, respectively. Danielsson
(2005) also found that one third of participants with ASD and epilepsy had their first
seizure before 24 months of age, and suggested that the risk for epilepsy is highest in the
first few years of life and decreases with age. Nomura and colleagues (2010) further
investigated age at onset, and found that there were two general “peak” ages at which
epilepsy began in individuals with autism: early in childhood at 3.2 years of age, and in
late adolescence at 16.7 years. Similarly, researchers have suggested that seizure
occurrence is highest in individuals with ASD at 5 and 10 years of age (Matson & Neal,
2009). These findings may help to explain the discrepancies in reported age at onset
across studies.
Factors Associated with Seizures
Several interrelated factors are thought to be associated with the presence of
seizures in individuals with ASD. The most well-established is cognitive ability. The
bulk of the research on epilepsy and seizures and comorbid intellectual disability (ID) in
individuals with ASD indicates that seizures are positively associated with lower
cognitive or intellectual functioning (Amiet et al., 2008; Bolton et al., 2011; Danielsson
et al., 2005; Gabis et al., 2005; Hrdlicka et al., 2004; Jokiranta et al., 2014; Viscidi et al.,
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2013). Amiet and colleagues (2008) found that the rate of epilepsy was 21.4% in
individuals with comorbid ASD and ID, but was only 8% in individuals with ASD
without ID. The authors further investigated this relationship and found that this
increased prevalence rate was found only for individuals with an intelligence quotient
(IQ) of less than 50 compared to those with an IQ of above 70; no significant differences
in rates of epilepsy were found between those with IQ between 50 and 70 and those with
IQs above 70. This indicates that moderate and severe ID, but not mild ID, may be
associated with increased rates of epilepsy. These rates are consistent with those reported
by Mouridsen and colleagues (2011), which were seizure rates of 33.7% for those with
IQs below 70 and 8.8% for those without ID.
In addition to lower cognitive functioning, Bolton and colleagues (2011) also
found that individuals with epilepsy also had greater deficits in speech and language
abilities, though this is in contrast to Shubrata and colleagues’ (2014) outcome that there
were no differences in receptive or expressive language. Although the relationship
between seizures and language abilities is currently unclear, evidence of decreased
cognitive functioning could be extrapolated to suggest that language impairments related
to lower intellectual functioning may be associated with seizures and seizure disorder.
The second factor is severity of ASD symptomology. Researchers have found
that individuals in the more impaired range of autism symptoms have higher rates of
abnormal electroencephalograms and epilepsy (Gabis et al., 2005). Shubrata and
colleagues (2014) also found that individuals with comorbid epilepsy had lower social
quotient and higher scores on measures of autism symptoms (i.e., Childhood Autism
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Rating Scale [CARS]). This provides evidence that ASD symptoms may be related to the
presence of epilepsy.
However, there is some evidence that this relationship may be more strongly
influenced by the level of cognitive functioning than core symptoms of ASD. For
instance, Viscidi and colleagues (2013) found that more severe ASD symptoms were not
independently associated with epilepsy, as there was not a significant association after
controlling for IQ. This indicates that intellectual functioning may play more of a role in
susceptibility to seizures than ASD symptomology, and Viscidi and colleagues (2013)
suggested that children with ASD may be at an increased risk for epilepsy because they
are at an increased risk for ID. Interestingly, Smith and Matson (2010) reported that in a
sample of adults with ID, those with comorbid ASD and epilepsy demonstrated greater
impairment in social skills than those with ASD but without epilepsy. These results
indicate that in a sample of individuals with diagnoses of both ASD and ID, individuals
with comorbid seizures had greater deficits in social functioning. Overall, while the
relationship between seizure disorders and autism symptomology independent of
intellectual disability is not well established, there is some evidence of an association.
The third factor is gender, as females with ASD are more likely to experience
seizures than males (Amiet et al., 2008; Bolton et al., 2011). Amiet and colleagues (2008)
and Bolton and colleagues (2011) both reported prevalence of seizures in 30-34.5% of
females and 18-18.5% of males with ASD. This discrepancy is consistent with the
findings of Danielsson and colleagues (2005), who suggested that epilepsy was present in
58% of females and 32% of males. However, other researchers have failed to find gender
differences in prevalence (Hara, 2007).
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Researchers have suggested that this may be connected to lower cognitive
functioning in females with ASD compared to males (Danielsson et al., 2005; Gabis et
al., 2005; Reilly & Gillberg, 2016). Nonetheless, there is some evidence that these
factors may be unrelated. Blackmon and colleagues (2016) further investigated this
relationship by examining treatment resistant epilepsy. They found that females
displayed higher rates of treatment resistant epilepsy, but also had lower overall autism
symptom severity. These results suggest that females with ASD and comorbid epilepsy
may represent a subtype characterized by higher risk for epilepsy phenotype and less
severe ASD symptoms. This is consistent with the findings of Bolton and colleagues
(2011) that the level of cognitive functioning and language skills did not differ
significantly between males and females with comorbid ASD and epilepsy.
An additional factor that has been investigated is regression in young children
with ASD. Previous studies have yielded inconsistent results as to whether children who
experience a regression are more likely to develop seizures. For instance, some research
implies that epileptiform abnormalities, paroxysmal abnormalities, and epilepsy were not
associated with regression (Bolton et al., 2011; Canitano, Luchetti, & Zappella, 2005;
Cuccaro et al., 2011; Kobayashi & Murata, 1998; Tuchman & Rapin, 1997). In contrast,
other researchers have found that regression was more frequent in individuals with
epilepsy than those without (Hrdlicka et al., 2004). Similarly, Giannotti and colleagues
(2008) reported that epilepsy and epileptiform abnormalities were more common in
children with ASD who regressed than those who did not. However, despite some
evidence for this association, the research overall does not support a potential relationship
between regression and epilepsy.
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Assessment and Treatment Considerations
A diagnosis of ASD may indicate certain barriers to the identification of a seizure
disorder. Core symptoms of ASD, such as lack of response to socially salient stimuli
(e.g., responding to name, voices) or repetitive behaviors, may obscure seizure symptoms
(Jokiranta et al., 2014; Peake, Notghi, & Philip, 2006; Reilly & Gillberg, 2016). Given
the high prevalence of seizures and seizure disorders in individuals with ASD, clinicians
are encouraged to consider this potential comorbidity during assessment (Matson & Neal,
2009).
Individuals with epilepsy are at risk for cognitive impairment (Berg, Zelko, Levy,
& Testa, 2012) and behavioral abnormalities (Elger, Helmstaedter, & Kurthen, 2004;
Vingerhoets, 2006). Baker and colleagues (2011) found that individuals with recent
diagnoses of epilepsy demonstrated a distinct cognitive trajectory compared to those
without epilepsy, and specifically displayed declines in memory, psychomotor speed and
executive functioning over the course of a year. The use of AEDs has also been
implicated in cognitive deficits, possibly due to neuronal sensitivity and excitability
(Meador, 2002). Berg and colleagues (2004) also found that young children with onset of
seizure before age 3 showed declines in age appropriate adaptive skills over time. As
cognitive impairments and adaptive skill deficits are already present in many individuals
with ASD, the presence of comorbid seizures or epilepsy have significant implications
for functioning in this population. As previously mentioned, although the association
between ASD and seizures is well-established, little is currently known about the
mechanisms that underlie this relationship. Consequently, early identification and
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effective treatment of seizure disorders are crucial steps in optimizing outcomes for
individuals with ASD.
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Purpose
Many individuals with ASD have co-occurring psychiatric disorders or medical
concerns, and disorders such as epilepsy can complicate the diagnostic process as well as
treatment planning. Although many researchers have investigated possible neurological
differences between individuals with ASD and TD individuals, the relationship between
ASD and neurological dysfunction (such as that characteristic of epilepsy or epileptiform
abnormalities) is still unclear. However, the literature does suggest that individual with
more severe ASD symptomology and cognitive impairment show higher rates of seizures
or seizure disorders (Amiet et al., 2008; Bolton et al., 2011; Gabis et al., 2005). These
findings indicate that there may be neurological underpinnings to ASD in some
individuals (Tuchman & Rapin, 2002).
The current study aimed to examine the relationship between ASD diagnosis and
a history of seizures and autism symptom severity. Although the previous literature
suggests that severe autism symptomology is related to comorbid seizures (Gabis et al.,
2005), very few studies have investigated specific symptoms. Additionally, few
researchers have explored this association in children under the age of 3. Expanding this
line of research to younger children may help to elucidate whether these differences are
consistent early in life, or if they become more apparent with age. Therefore, the current
study investigateed differences in total symptomology as well as symptoms within
specific domains (i.e., social communication, restricted repetitive interests and behaviors,
and communication) in infants and toddlers with and without a history of seizures and
with and without an ASD diagnosis. The extant literature on ASD and seizure disorders
provides some evidence that ASD symptoms may be exacerbated in individual with ASD
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and co-occurring seizures (Gabis et al., 2005; Shubrata et al., 2014). Therefore, it was
hypothesized that across both total and domain scores individuals with comorbid ASD
and a history of seizures would have the highest symptomology, followed by the ASD
without seizures group, and the atypical group without seizures will have the lowest
scores. The results of the current study may have clinical implications for assessment
and treatment of ASD comorbid with a history of seizures or seizure disorder.
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Method
Participants
All participants were enrolled in EarlySteps, Louisiana’s statewide early
intervention program under the Individuals with Disabilities Education Act, Part C. The
data for this study were extracted from an existing dataset containing assessment
information. Children under 3 years of age qualify for EarlySteps services if they have or
are at risk for a developmental delay. Therefore, all participants included from this
dataset had some form of atypical development. Only participants between the ages of 17
and 37 months at the time of assessment were included in the analyses.
Participants were assigned to groups based on whether they meet criteria for ASD
and whether they had a history of seizures or a seizure disorder. Diagnoses of ASD were
given by a licensed clinical psychologist based on an algorithm in accordance with the
Diagnostic and Statistical Manual, Fifth Edition (DSM-5, American Psychiatric
Association, 2013). A classification of a history of seizures or seizure disorder was based
on parental report of any seizures on the demographic subsection of the Baby and Infant
Screen for Children with aUtIsm Traits (BISCUIT; Matson, Boisjoli, & Wilkins, 2007).
Participants were assigned to one of four groups: an atypical development group without
a history of seizures (ATYP), an atypical group with a history of seizures (ATYP+SEIZ),
an ASD only group without history of seizures (ASD), and a comorbid ASD and seizures
group (ASD+ SEIZ).
A statistical power analysis program, G*POWER, was used to establish necessary
samples size for the four groups in order to demonstrate adequate power. A power of .80
(Field, 2013), alpha of .05, and medium effect size of ƞ2 = .25 were used, as these values
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are considered acceptable and consistent with previous research in the field. The results
of this analysis indicated that a total sample size of 180, or approximately 45 participants
per group, would yield the appropriate power and effect size for a one-way ANOVA, and
a total sample size of 24 would yield the appropriate power for the MANOVA.

Figure 1. Participant Inclusion Flowchart
The total number of cases in the dataset was 17,996. Cases were excluded if the
evaluation was conducted prior to 2010 or if there was missing data. Exclusion of cases
entered prior to 2010 was to control for the potential effects of a natural disaster in the
region (i.e., flooding and displacement due to Hurricane Katrina) on children who were
born prior to that event. As none of the cases with missing data were in the smallest
group (ASD+SEIZ) and therefore deletion did not affect the total sample size for the
study, deletion of these cases was used rather than estimation of missing data
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(Tabachnick & Fidell, 2007). If a participant had received more than one evaluation, the
most recent was included in the analyses. For the exact number of cases excluded, see
Figure 1.
The total number of cases remaining was 9,410 (i.e., 8,164 ATYP, 1,024 ASD,
174 ATYP+SEIZ, and 48 ASD+SEIZ). Due to unequal sample sizes between groups,
participants from each group were age and gender and gender matched to the smallest
group (i.e., ASD+SEIZ). This matching procedure was used because, as previously
discussed, previous research has shown that there are age and gender effects related to
seizures and developmental functioning, so these demographic factors were controlled for
through matching to the smallest group. This resulted in a total of 192 participants, with
48 participants in each group. For one participant in the ATYP+SEIZ group, it was not
possible to match exactly for age and gender. Consequently, this case was matched with a
case within one month of age (e.g., 24 months instead of 23 months). The age range for
the participants was 17-35 months (M = 25.89, SD = 4.59). In regard to the total sample,
58.3% were male (n = 112) and 41.7% (n =80) were female. With respect to participant
race, 47.9% were African American (n = 92), 42.2% were Caucasian (n = 81), 4.2% were
Hispanic (n = 8), and 5.7% were of another race (n = 11). Group demographic
information is presented in Table 1.
Measures
Baby and Infant Screen for Children with aUtIsm Traits, Part 1 (BISCUITPart 1; Matson et al., 2007).
The BISCUIT is an informant-report measure designed for young children 17 to
37 months of age. This measure consists of three sections which evaluate ASD
symptomology, comorbid psychopathology, and challenging behaviors. The BISCUIT-
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Part 1 assesses ASD symptoms and consists of 62 items related to nonverbal and verbal
communication, socialization, and repetitive behavior/restricted interests. Each of these
items is rated based on a 3-point Likert scale that compares the child to same-aged peers.
A rating of 0 corresponds to “not different; no impairment”, a rating of 2 corresponds to
“somewhat different; mild impairment”, and a rating of 3 corresponds to “very different;
severe impairment”. This measure includes age-based cut-off ranges for the total
BISCUIT score; a score of 0-16 falls within the “No ASD/Atypical Development” range;
a score of 17-38 falls within the “Possible ASD” range; and a score of 41-124 falls within
the “Probable ASD” range. Therefore, a score of 17 or higher is classified as in the “at
risk” range. The Socialization/Nonverbal Communication subscale consists of 24 items,
the Repetitive Behavior/Restricted Interests subscale includes 23 items, and the
Communication subscale includes 7 items.
Table 1. Demographics
ATYP

ATYP+SEIZ

ASD

ASD+SEIZ

(n = 48)

(n = 48)

(n = 48)

(n=48)

Mean Age (in months)

25.88

25.90

25.88

25.88

SD (in months)

4.47

4.72

4.74

4.74

Male

28 (58.3%)

28 (58.3%)

28 (58.3%)

28 (58.3%)

Female

20 (41.7%)

20 (41.7%)

20 (41.7%)

20 (41.7%)

African American

23 (47.9%)

18 (37.5%)

24 (50.0%)

27 (56.3%)

Caucasian

19 (39.6%)

27 (56.3%)

20 (41.7%)

15 (31.3%)

Hispanic

5 (10.4%)

0 (0%)

1 (2.1%)

2 (4.2%)

Other

1 (2.1%)

3 (6.3%)

3 (6.3%)

4 (8.3%)

Gender

Race

The BISCUIT-Part 1 has an estimated internal reliability of .87 and overall
correct classification rate of .89 ( Matson et al., 2009). The BISCUIT-Part 1 has also
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been found to have convergent validity with the Modified Checklist for Autism in
Toddlers (M-CHAT) and the Personal-Social domain of the Battelle Developmental
Inventory, Second Edition (BDI-2), as well as divergent validity through small correlation
with the BDI-2’s Adaptive and Motor domains (Matson, Wilkins, & Fodstad, 2011). The
present study used the BISCUIT-Part 1 total score and domains scores, as well as the
demographic form. The demographic form is used to collect information regarding the
participant’s demographic variables, family history, and developmental and medical
history. The BISCUIT-1 total score were used to assess ASD symptom severity, and the
subscale scores were used to assess symptomology across nonverbal
communication/socialization, repetitive behavior/restricted interests, and communication.
Procedure
The Louisiana State University institutional review board and the State of
Louisiana’s Office for Citizens with Developmental Disabilities approved the study prior
to data collection. The BISCUIT-Part 1 were administered by service providers at the
participant’s home or daycare center as part of an assessment battery that included
caregiver interviews and direct observation. All service providers attended trainings on
the administration of the assessment measures and held a degree, certification, and/or
licensure in various related fields such as occupational therapy, physical therapy,
psychology, special education, and speech-language pathology. Only records collected
between 2010-2016 were included in the statistical analyses.
The data used for the present study were from a research database of de-identified
archival records. Consequently, the Institutional Review Board determined that the 45
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CFR part 46 of the U.S. Department of Health and Human Services regulation does not
apply and informed consent was not required.
Statistical Analyses
Bivariate and univariate analyses were conducted to investigate the following
research questions: 1) does autism symptom severity differ based on a history of seizures
or seizure disorder and 2) does a history of seizures or seizure disorder impact separate
domains of ASD symptoms differently? The four groups were age and gender-matched
to the smallest group, so a priori analyses of differences in these demographic variables
were not included, though a chi-square analysis was conducted to assess differences in
race between groups. Descriptive statistics were conducted for total scores on the
BISCUIT-Part 1 and the three subscales.
An analysis of variance (ANOVA) was conducted to examine the relationship
between group and total ASD symptom severity. The independent variable (IV) was
group (i.e., ATYP, ASD, ATYP+SEIZ, and ASD+SEIZ) and the dependent variable
(DV) was ASD symptom severity, based on the total BISCUIT-Part 1 score. Post hoc
tests were used to further examine differences between groups. A multivariate analysis
of variance (MANOVA) was conducted with group as the IV and scores from the three
ASD symptom subscales (i.e., Socialization/Nonverbal Communication, Repetitive
Behavior/Restricted Interests, Communication) as the DVs. Post-hoc comparisons were
done to further investigate differences between groups.
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Results
Bivariate analyses were not conducted for age or gender because matching was
applied to all group; however, the results of a chi-squared analysis revealed no significant
differences between groups in regard to race, χ2 (9) = 14.25, p = .114). Internal
consistency for the 62 items on the BISCUIT Part-1 was estimated to be a = .97. Prior to
performing the initial ANOVA, the data were checked for outliers in total score on the
BISCUIT-Part 1. Results indicated that there were outliers in the ATYP and ASD+SEIZ
groups. A square root transformation was then applied to the score dependent variable to
address these outliers because the scores were moderately positively skewed. Due to the
large samples size (n > 50), normal distribution was assessed by Normal QuantileQuantile (Q-Q) rather than by the Komogrov-Smirnov and Shapiro-Wilks tests (Field,
2013; Laerd, 2015). Based on visual analysis of Normal Q-Q Plots, it was determined
that scores for all three subscales were normally distributed. The initial ANOVA showed
significant differences in total symptom severity between groups, F (3,188) = 90.97, p >
.001, partial η2 = .592. Descriptive statistics for the total BISCUIT-Part 1 scores across
groups are provided in Table 2. Levene’s Test of Equality of error variance was
significant (p = .023), so Games-Howell post hoc tests were used. The results of GamesHowell post hoc tests indicated that all groups had significantly different total scores on
the BISCUIT- Part 1 (p < .001).
Prior to conducting the MANOVA, the assumptions for this analysis were
checked. There were univariate outliers in the data for all three subscales of the
BISCUIT- Part 1, as determined by inspection of boxplots for values greater than 1.5
lengths from the box. Based on observation of histograms, it was determined that the
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data for the Socialization/ Nonverbal communication and RRBIs domains subscales was
strongly positively skewed, while the Communication domain was strongly negatively
skewed. Therefore, logarithmic transformations were conducted for the first two
subscales and a reflect and logarithmic transformation was applied to the Communication
domain. Following these transformations, there were no univariate outliers for the any of
the domains. Based on visual analysis of Normal Q-Q Plots, it was determined that
scores for all three subscales were normally distributed. Multicollinearity was assessed
through a linear regression analysis using the principle proposed by Belsley, Kuh, and
Welsch (1980; from Tabachnick & Fidell, 2007). Although the final dimension had more
than one variance proportion greater than .50, none of the condition indices approached
30; therefore, multicollinearity was not detected. There was a linear relationship between
the Socialization/Nonverbal Communication, RRBIs, and Communication as assessed by
scatterplot. There were no multivariate outliers, as assessed by Mahalanobis distance (p
> .001), using a critical value of 16.27 based on the number of dependent variables.
Table 2. Autism symptom severity comparison between groups
ATYP

ATYP+SEIZ

ASD

ASD+SEIZ

M (SD)

M (SD)

M (SD)

M (SD)

18.54 (14.92)bcd

32.50 (18.75)acd

75.79 (19.61)abd

57.69 (21.76)abc

Socialization/Nonverbal
Communication

5.58 (7.99)bcd

13.48 (11.32)cd

33.48 (9.14)abd

26.21 (12.02)abc

Restricted/Repetitive
Behaviors/Interests

4.06 (5.02)cd

6.38 (6.18)cd

23.10 (10.17)abd

16.19 (9.74)abc

Communication

7.13 (3.81)bcd

10.23 (2.05)ac

12.38 (2.01)ab

BISCUIT-Part 1:
ASD Symptom Severity

a.
b.
c.
d.

Significantly different from ATYP, p < .05
Significantly different from ATYP+SEIZ, p < .05
Significantly different from ASD, p < .05
Significantly different from ASD+SEIZ, p < .05
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11.40 (2.89)a

Note: M = Mean; SD = Standard Deviation.

A MANOVA was then conducted to evaluate scores across symptom domains
(see Figure 2). There was not homogeneity of variance-covariances matrices, as assessed
by Box’s test of equality of covariance matrices (p < .001). Although the sample sizes
across groups were equal and therefore a violation of this assumption is typically not
considered a concern, Pillai’s Trace was used rather than Wilks’ Lambda as it is more
robust to violations of assumptions (Field, 2013; Laerd Statistics, 2013). There was not
homogeneity of variances for any of the subscales, as assessed by Leven’s Test of
Equality of Error Variances (p < .001 for Socialization/Nonverbal Communication and
RRBIs, and p = .019 for Communication). Therefore, Games-Howell post hoc tests were
conducted for follow-up ANOVAs (Laerd Statistics, 2015).

35.00

33.48

30.00
23.10

Subscale Score

25.00

26.21

20.00
15.00
10.00

16.19

13.48
7.13

12.38

11.40

Socialization/
Nonverbal
Communication
Repetitve
Behavior/Restrict
ed Interests

10.23
Communication

5.00

5.58

6.38

4.06

ATYP

ATYP+SEIZ

ASD

ASD+SEIZ

Group

Figure 2. Mean Group Scores Across Subscales
According to Pillai’s trace, there were significant differences between groups
across symptoms, V = .644, F(9,564) = 17.13, p < .001, partial η2 = .215. Follow-up
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ANOVAs were also conducted, and a Bonferroni correction (p < .017) was used to
account for multiple comparisons. There were significant differences between groups for
all three domains: Socialization/nonverbal communication domain, F (3,188) = 73.88, p
> .001, partial η2 = .541; RRBI domain, F(3,188) = 63.55, p > .001, partial η2 = .504,
and the Communication domain F(3,188) = 25.78, p > .001, partial η2 = .292.
Games-Howell post hoc tests were conducted to evaluate differences between
groups across symptom domains because the assumption of homogeneity of variances
was violated (Laerd Statistics, 2015). For the Socialization/Nonverbal communication
domain, the ASD+SEIZ group had significantly higher score than both the ATYP and
ATYP+SEIZ groups (p < .001) and significantly lower scores than the ASD group (p =
.003). The ATYP+SEIZ group also had significantly higher scores than the ATYP group
(p < .001) and lower scores than the ASD group (p < .001). Lastly, the ASD group also
had significantly higher scores than the ATYP group (p < .001).
For the Restricted/repetitive behaviors and interest domain, the ASD+SEIZ group
had significantly lower scores than the ASD group (p = .002) and higher scores than both
the ATYP and ATYP+SEIZ groups (p < .001). The ATYP+SEIZ group had significantly
lower scores than the ASD group (p < .001), but did not differ significantly from the
ATYP group (p = .094). The ASD group also had significantly higher scores than the
ATYP group (p < .001).
In regard to the Communication subscale, the ATYP group had significantly
lower scores than all three of the other groups (p < .001). The ATYP+SEIZ group had
significantly lower scores than the ASD group (p = .001), but did not differ significantly
from the ASD+SEIZ group (p = .194). ASD group also had significantly higher scores
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than the ATYP (p < .01) and the ATYP+SEIZ (p = .001) groups. Significant differences
were not found for the ASD and ASD+SEIZ groups on this domain (p = .365).
Descriptive statistics for the BISCUIT-Part 1 subscale scores across groups are provided
in Table 2.
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Discussion
ASD symptomology, as measured by the BISCUIT-Part 1, was compared
between groups of participants with atypical development, atypical development and
comorbid seizures, ASD, and comorbid ASD and seizures. Total ASD symptom scores
were examined, as well as symptoms on three symptom domains: Socialization/nonverbal
communication, Restricted/repetitive behaviors and interests, and Communication.
The findings of this study indicated that there were significant differences
between groups for the total BISCUIT-Part 1 scores as well as between most groups for
symptom domains. Across all IVs, the ASD group had the highest scores, followed by
the ASD+SEIZ group, then the ATYP+SEIZ group, with the ATYP group evincing the
lowest scores. Differences were significant between all four groups for the total score
and Socialization/nonverbal communication. The majority of comparisons were
significant for the other two domains. Exceptions included the ATYP and ATYP+SEIZ
groups for the RRBIs domain and the ASD+SEIZ and the ASD and ATYP+SEIZ groups
for the Communication subscale.
The general trend of these findings was that for individuals with ASD, a history of
seizures indicated lower endorsement of symptoms. Conversely, for individuals without
ASD, a history of seizures was related to higher overall symptomology. These results
contradict some previous findings that individuals in the more impaired range of ASD
(i.e., autism rather than Asperger’s syndrome or PDD-NOS) demonstrate higher
likelihood to experience seizures (Gabis et al., 2005), as comorbid seizures were
associated with lower rates of ASD symptoms in the current study. Other researchers
have found that, based on DSM-IV-TR diagnoses, epilepsy occurs at higher rates in both
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autistic disorder and PDD-NOS than in Asperger’s syndrome (El Achkar & Spence,
2015). Nonetheless, given that there is a well-documented relationship between seizures
and ID, these results are consistent with the assumption that children with seizures may
have more cognitive impairment than those without seizures. Therefore, atypically
developing children with seizures and therefore potential ID may exhibit more symptoms
related to ASD (e.g., language delays, motor stereotypies) than those without ASD or
seizures. Further, in young children with ASD, those with comorbid seizures and
possible lower cognitive functioning may have lower overall developmental functioning.
This does not, however, necessarily suggest more autism-specific symptoms but rather
more global impairments.
For the RRBIs subscale, a history of seizures was not related to significantly
higher levels of restricted, repetitive interests and behaviors in the atypically developing
sample. Conversely, in the ASD sample, those without a history of seizures had
significantly higher scores on the RRBIs domain than those with seizures. This finding
may suggest that in atypically developing children, neurological differences related to
seizures may not be significantly associated with increases in restricted, repetitive
interests and/or behaviors in individuals without ASD. The differences between the ASD
and atypically developing groups may indicate that seizures may be more closely related
to RRBIs in young children with ASD, but less intertwined in children without ASD.
A history of seizures also seemed to be less robustly related to communication
and language skills, as there were fewer significant differences between groups for this
domain. Specifically, the Communication score in the ASD+SEIZ group did not differ
from ASD or ATYP+SEIZ groups. The results for this domain indicated that the
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atypically developing group had significantly less impairment in communication than the
other three groups, but that those with atypical development and seizures did not have
significantly fewer communication difficulties than those with ASD and seizures.
Further, the ASD group did not have significantly worse communication skills than the
ASD+SEIZ group. These results indicate that seizures may play more of a role in
impairments in communication than an ASD diagnosis. Of note, this finding may be
accounted for by the small number of items (7 as compared to 24 and 23). Given that this
domain is not a diagnostic criterion for ASD according to DSM-5, and the fact that there
are so few items, these findings may have less substantial implications for the field.
However, because so many children with ASD do experience language delays and
impairments, this subscale was included in the analyses to examine general trends
between groups.
An important consideration in the interpretation of these findings is the very
young age of the participants. Previous research indicates that many individuals do not
develop seizures until later in childhood or adolescence (Bolton et al., 2011; Hara et al.,
2007). There is substantial evidence that earlier onset of seizures may be related to
greater cognitive impairment (Berg et al., 2012; O’Leary et al., 1981; Vasconcellos et al.
2001). Physical disabilities such as motor impairments may also be more prevalent in
children with seizures (McGrother et al., 2006). Therefore, this sample may represent a
group of children with greater global delays associated with early onset seizures, which
may account for some of the observed differences between groups.
Additionally, it is likely that many of the children whose seizures had been
identified at this young age were exhibiting types of seizures with more visible motor
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features (e.g., tonic-clonic seizures), rather than less obvious symptoms (e.g., absence
seizures), which would be more difficult to identify in younger children, particularly with
communication deficits. Therefore, it is possible that some children in this sample may
have had undiagnosed seizures at the time of assessment.
Overall, the evidence that a history of seizures may be significantly related to
autism symptomology both in atypically developing children and those with ASD
highlights the importance of early identification. In this sample, those with ASD and
comorbid seizures had lower autism symptomology scores than those without seizures,
and it is possible that this is due to impairments in cognitive functioning. Further, young
children without ASD had higher scores of ASD symptomology if they had a history of
seizures, which may indicate impairments in the three domains discussed even in the
absence of a diagnosis of a developmental disability when there is abnormal neurological
activity.
Although there is currently a lack of consensus in the field regarding screening
procedures for epilepsy in those with ASD, this study supports the recommendations of
researchers such as El Achkar and Spence (2015) that providers be proficient in
differentiating ASD symptoms from potential indicators of seizures. Given the increased
prevalence of seizures in the ASD population (Jokiranta et al., 2014) and the potential
association with symptomology (Gabis et al., 2005) and cognitive impairments (Amiet et
al., 2008; Bolton et al., 2011; Danielsson et al., 2005), providers should take additional
care in considering the likelihood of seizure disorder.
Early identification of seizures in young children with ASD is crucial, as
researchers have recommended that individuals with this comorbidity may evince
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different patterns of symptoms and may require longitudinal follow-up throughout
development to monitor the seizures (Shubrata et al., 2014). Tuchman and colleagues
(2010) suggested that early recognition and diagnosis of seizures may also help identify
children who may be at-risk for ASD, given the high incidence of these two conditions.
Early treatment of seizures, such as medication or lifestyle changes, may help to improve
outcomes for individuals with ASD (Tuchman et al., 2010). However, Reilly & Gillburg
(2016) caution that consideration of potential side effects of anti-epileptic medication
should be considered in this population.
Limitations
One limitation to the current study is the lack of a typically developing
comparison group. Given that children were included in the EarlySteps database if their
caregivers requested an evaluation due to concerns regarding their child’s development,
most children in this sample evinced some sort of developmental delay or medical
concern. Although this allowed for a comparison between children with and without
ASD and with and without a history of seizures, these results may not be generalizable to
comparisons between children with ASD and typically developing children.
Additionally, the BISCUIT demographic form is a caregiver-report measure, and
therefore classification of having a history of seizures was based solely on caregiver
report and was not validated through medical records. Finally, the results for the
Communication subscale should be interpreted with caution due to the small number of
items in this domain. This domain was still included in the analyses because many
children with ASD experience language delays.
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Future Directions
These findings highlight the need for additional research on how seizure disorders
affect symptom presentation in children with ASD. This study provides preliminary
evidence that seizures in individuals with ASD may be related to lower levels of autismspecific symptoms as compared to children with ASD alone. These results should be
further investigated, both in young children as well as in older children where ID can be
investigated as a variable to further elucidate the relationship between autism
symptomology, intellectual disability, and seizures. The sample of participants used in
this study was too young for an ID diagnosis to be used as a reliable variable in the
present analyses, but it is hypothesized that the findings on a history of seizure disorders
may be associated with lower cognitive functioning. Although many studies have
considered comorbidity of ASD, ID, and seizure disorders, the majority have focused on
cognitive functioning and few have investigated autism symptomology specifically.
As the current study relied upon caregiver-report of a history of seizures,
information regarding the type or frequency of seizures was not available. Although
some studies have focused on specific types of seizures (Reilly & Gillburg, 2016),
additional research is warranted. Further, the demographics of this sample upheld
previous research that female gender may serve as a risk factor for epilepsy in individuals
with ASD (El Achkar & Spence, 2015). Despite the overall gender ratio of 4-5:1 male to
female with ASD (Baio, 2014), the sample of individuals with ASD used in this study
included 28 males and 20 females, which is a more even gender split than the general
ASD population. Although gender was not included as a variable in this study due to the
age and gender matching procedure applied to the four groups, future investigation of the
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differences between males and females with comorbid ASD and seizures may help to
elucidate the relationship between seizures, ASD, and ID.
Future studies involving young children should be considered to further clarify
symptom patterns in very young children with a history of seizures. As the literature
indicates that seizure disorders do not develop or are not diagnosed until later in
childhood, additional investigation of how seizures early in development relate to ASD
and associated impairments is warranted.

42

References
American Psychiatric Association. (1980). DSM-III: Diagnostic and Statistical Manual
of Psychiatric Disorders. Washington.: APA.
American Psychiatric Association. (1987). DSM-III-R: Diagnostic and Statistical Manual
of Mental Disorders. Washington, DC.: APA.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental
disorders (4th ed.). Washington, DC: American Psychiatric Association.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental
disorders (5th ed.). Washington, DC: American Psychiatric Association.
Amiet, C., Gourfinkel-An, I., Bouzamondo, A., Tordjman, S., Baulac, M., Lechat, P., …
Cohen, D. (2008). Epilepsy in autism is associated with intellectual disability and
gender: Evidence from a meta-analysis. Biological Psychiatry, 64(7), 577–582.
https://doi.org/10.1016/j.biopsych.2008.04.030
Baio, J. (2014, March 28). Prevalence of autism spectrum disorder among children aged
8 years. Retrieved November 14, 2015, from
http://www.cdc.gov/mmwr/preview/mmwrhtml/ss6302a1.htm?s_cid=ss6302a1_w
Baker, G. A., Nashef, L., & van Hout, B. A. (1997). Current Issues in the Management of
Epilepsy: The Impact of Frequent Seizures on Cost of Illness, Quality of Life, and
Mortality. Epilepsia, 38, S1–S8. https://doi.org/10.1111/j.15281157.1997.tb04511.x
Baker, G. A., Taylor, J., Aldenkamp, A. P., & on behalf of the SANAD group. (2011).
Newly diagnosed epilepsy: Cognitive outcome after 12 months. Epilepsia, 52(6),
1084–1091. https://doi.org/10.1111/j.1528-1167.2011.03043.x
Ballaban-Gil, K., & Tuchman, R. (2000). Epilepsy and epileptiform EEG: Association
with autism and language disorders. Mental Retardation and Developmental
Disabilities Research Reviews, 6(4), 300–308. https://doi.org/10.1002/10982779(2000)6:4<300::AID-MRDD9>3.0.CO;2-R
Berg, A. T., Berkovic, S. F., Brodie, M. J., Buchhalter, J., Cross, J. H., Van Emde Boas,
W., … Scheffer, I. E. (2010). Revised terminology and concepts for organization
of seizures and epilepsies: Report of the ILAE Commission on Classification and
Terminology, 2005–2009. Epilepsia, 51(4), 676–685.
https://doi.org/10.1111/j.1528-1167.2010.02522.x
Berg, A. T., Smith, S. N., Frobish, D., Beckerman, B., Levy, S. R., Testa, F. M., &
Shinnar, S. (2004). Longitudinal Assessment of Adaptive Behavior in Infants and
Young Children With Newly Diagnosed Epilepsy: Influences of Etiology,

43

Syndrome, and Seizure Control. Pediatrics, 114(3), 645–650.
https://doi.org/10.1542/peds.2003-1151-L
Berg, A. T., Zelko, F. A., Levy, S. R., & Testa, F. M. (2012). Age at onset of epilepsy,
pharmacoresistance, and cognitive outcomes A prospective cohort study.
Neurology, 79(13), 1384–1391. https://doi.org/10.1212/WNL.0b013e31826c1b55
Bishop, D. V. M. (1985). Age of Onset and Outcome in “Acquired Aphasia with
Convulsive Disorder” (Landau-Kleffner Syndrome). Developmental Medicine &
Child Neurology, 27(6), 705–712. https://doi.org/10.1111/j.14698749.1985.tb03793.x
Blackmon, K., Bluvstein, J., MacAllister, W. S., Avallone, J., Misajon, J., Hedlund, J., …
Devinsky, O. (2016). Treatment Resistant Epilepsy in Autism Spectrum Disorder:
Increased Risk for Females. Autism Research, 9(2), 311–320.
https://doi.org/10.1002/aur.1514
Bolton, P. F., Carcani-Rathwell, I., Hutton, J., Goode, S., Howlin, P., & Rutter, M.
(2011). Epilepsy in autism: features and correlates. The British Journal of
Psychiatry, 198(4), 289–294. https://doi.org/10.1192/bjp.bp.109.076877
Brooks-Kayal, A. (2010). Epilepsy and autism spectrum disorders: Are there common
developmental mechanisms? Brain and Development, 32(9), 731–738.
https://doi.org/10.1016/j.braindev.2010.04.010
Camfield, C. S., Camfield, P. R., Gordon, K., Wirrell, E., & Dooley, J. M. (1996).
Incidence of Epilepsy in Childhood and Adolescence: A Population-Based Study
in Nova Scotia from 1977 to 1985. Epilepsia, 37(1), 19–23.
https://doi.org/10.1111/j.1528-1157.1996.tb00506.x
Canitano, R., Luchetti, A., & Zappella, M. (2005). Epilepsy, Electroencephalographic
Abnormalities, and Regression in Children With Autism. Journal of Child
Neurology, 20(1), 27–31. https://doi.org/10.1177/08830738050200010401
Chawarska, K., Shic, F., Macari, S., Campbell, D. J., Brian, J., Landa, R., … Bryson, S.
(2014). 18-Month Predictors of Later Outcomes in Younger Siblings of Children
With Autism Spectrum Disorder: A Baby Siblings Research Consortium Study.
Journal of the American Academy of Child & Adolescent Psychiatry, 53(12),
1317–1327.e1. https://doi.org/10.1016/j.jaac.2014.09.015
Cuccaro, M. L., Tuchman, R. F., Hamilton, K. L., Wright, H. H., Abramson, R. K.,
Haines, J. L., … Pericak-Vance, M. (2011). Exploring the Relationship Between
Autism Spectrum Disorder and Epilepsy Using Latent Class Cluster Analysis.
Journal of Autism and Developmental Disorders, 42(8), 1630–1641.
https://doi.org/10.1007/s10803-011-1402-y

44

Danielsson, S., Gillberg, I. C., Billstedt, E., Gillberg, C., & Olsson, I. (2005). Epilepsy in
Young Adults with Autism: A Prospective Population-based Follow-up Study of
120 Individuals Diagnosed in Childhood. Epilepsia, 46(6), 918–923.
https://doi.org/10.1111/j.1528-1167.2005.57504.x
Dunn, O. J. (1964). Multiple comparisons using rank sums. Technometrics, 6, 241-252.
El Achkar, C. M., & Spence, S. J. (2015). Clinical characteristics of children and young
adults with co-occurring autism spectrum disorder and epilepsy. Epilepsy &
Behavior, 47, 183–190. https://doi.org/10.1016/j.yebeh.2014.12.022
Elger, C. E., Helmstaedter, C., & Kurthen, M. (2004). Chronic epilepsy and cognition.
The Lancet. Neurology, 3(11), 663–672. https://doi.org/10.1016/S14744422(04)00906-8
Ellenberg, J. H., Hirtz, D. G., & Nelson, K. B. (1984). Age at onset of seizures in young
children. Annals of Neurology, 15(2), 127–134.
https://doi.org/10.1002/ana.410150204
Field, A. (2013). Discovering Statistics using IBM SPSS Statistics (Fourth Edition
edition). Los Angeles: SAGE Publications Ltd.
Fisher, R. S., Boas, W. van E., Blume, W., Elger, C., Genton, P., Lee, P., & Engel, J.
(2005). Epileptic Seizures and Epilepsy: Definitions Proposed by the International
League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE).
Epilepsia, 46(4), 470–472. https://doi.org/10.1111/j.0013-9580.2005.66104.x
Fombonne, E. (2009). Epidemiology of pervasive developmental disorders. Pediatric
Research, 65(6), 591–598.
Freeman, J. M., Vining, E. P. G., Pillas, D. J., Pyzik, P. L., Casey, J. C., Lcsw, & Kelly,
and M. T. (1998). The Efficacy of the Ketogenic Diet—1998: A Prospective
Evaluation of Intervention in 150 Children. Pediatrics, 102(6), 1358–1363.
https://doi.org/10.1542/peds.102.6.1358
Frye, R. E. (2016). Prevalence, Significance and Clinical Characteristics of Seizures,
Epilepsy and Subclinical Electrical Activity in Autism. North American Journal
of Medicine and Science, 8(3). Retrieved from
http://najms.com/index.php/najms/article/view/86
Gabis, L., Pomeroy, J., & Andriola, M. R. (2005). Autism and epilepsy: Cause,
consequence, comorbidity, or coincidence? Epilepsy & Behavior, 7(4), 652–656.
https://doi.org/10.1016/j.yebeh.2005.08.008
Giannotti, F., Cortesi, F., Cerquiglini, A., Miraglia, D., Vagnoni, C., Sebastiani, T., &
Bernabei, P. (2008). An Investigation of Sleep Characteristics, EEG

45

Abnormalities and Epilepsy in Developmentally Regressed and Non-regressed
Children with Autism. Journal of Autism and Developmental Disorders, 38(10),
1888–1897. https://doi.org/10.1007/s10803-008-0584-4
Groesbeck, D. K., Bluml, R. M., & Kossoff, E. H. (2006). Long-term use of the
ketogenic diet in the treatment of epilepsy. Developmental Medicine & Child
Neurology, null(12), 978–981. https://doi.org/10.1017/S0012162206002143
Hara, H. (2007). Autism and epilepsy: A retrospective follow-up study. Brain and
Development, 29(8), 486–490. https://doi.org/10.1016/j.braindev.2006.12.012
Hartman, A. L., Gasior, M., Vining, E. P. G., & Rogawski, M. A. (2007). The
Neuropharmacology of the Ketogenic Diet. Pediatric Neurology, 36(5), 281–292.
https://doi.org/10.1016/j.pediatrneurol.2007.02.008
Hesdorffer, D. C., Logroscino, G., Benn, E. K. T., Katri, N., Cascino, G., & Hauser, W.
A. (2011). Estimating risk for developing epilepsy A population-based study in
Rochester, Minnesota. Neurology, 76(1), 23–27.
https://doi.org/10.1212/WNL.0b013e318204a36a
Hirtz, D., Thurman, D. J., Gwinn-Hardy, K., Mohamed, M., Chaudhuri, A. R., &
Zalutsky, R. (2007). How common are the “common” neurologic
disorders?. Neurology, 68(5), 326-337.
Holmes, G. L. (1997). Classification of Seizures and the Epilepsies. In S. C. Schachter &
D. L. Schomer (Eds.), The Comprehensive Evaluation and Treatment of Epilepsy:
A Practical Guide. San Diego, CA: Academic Press.
Howlin, P. (2006). Autism spectrum disorders. Psychiatry, 5(9), 320–324.
https://doi.org/10.1053/j.mppsy.2006.06.007
Hrdlicka, M., Komarek, V., Propper, L., Kulisek, R., Zumrova, A., Faladova, L., …
Urbanek, T. (2004). Not EEG abnormalities but epilepsy is associated with
autistic regression and mental functioning in childhood autism. European Child &
Adolescent Psychiatry, 13(4), 209–213. https://doi.org/10.1007/s00787-004-03537
Jokiranta, E., Sourander, A., Suominen, A., Timonen-Soivio, L., Brown, A. S., &
Sillanpää, M. (2014). Epilepsy Among Children and Adolescents with Autism
Spectrum Disorders: A Population-Based Study. Journal of Autism and
Developmental Disorders, 44(10), 2547–2557. https://doi.org/10.1007/s10803014-2126-6
Kang, J.-Q., & Barnes, G. (2012). A Common Susceptibility Factor of Both Autism and
Epilepsy: Functional Deficiency of GABAA Receptors. Journal of Autism and

46

Developmental Disorders, 43(1), 68–79. https://doi.org/10.1007/s10803-0121543-7
Kanner, L. (1943). Autistic disturbances of affective contact. Acta Paedopsychiatrica,
35(4), 100–136.
Kanner, L. (1971). Follow-up study of eleven autistic children originally reported in
1943. Journal of Autism and Childhood Schizophrenia, 1(2), 119–145.
Kawasaki, Y., Yokota, K., Shinomiya, M., Shimizu, Y., & Niwa, S. (1997). Brief Report:
Electroencephalographic Paroxysmal Activities in the Frontal Area Emerged in
Middle Childhood and During Adolescence in a Follow-up Study of Autism.
Journal of Autism and Developmental Disorders, 27(5), 605–620.
https://doi.org/10.1023/A:1025886228387
Kinsman, S. L., Vining, E. P. G., Quaskey, S. A., Mellits, D., & Freeman, J. M. (1992).
Efficacy of the Ketogenic Diet for Intractable Seizure Disorders: Review of 58
Cases. Epilepsia, 33(6), 1132–1136. https://doi.org/10.1111/j.15281157.1992.tb01770.x
Kobayashi, R., & Murata, T. (1998). Setback phenomenon in autism and longterm
prognosis. Acta Psychiatrica Scandinavica, 98(4), 296–303.
https://doi.org/10.1111/j.1600-0447.1998.tb10087.x
Laerd Statistics (2015). Statistical tutorial softward guides. Retrieved from
https://statistics.laerd.com/
Levisohn, P. M. (2007). The autism-epilepsy connection. Epilepsia, 48, 33–35.
https://doi.org/10.1111/j.1528-1167.2007.01399.x
Leyfer, O. T., Folstein, S. E., Bacalman, S., Davis, N. O., Dinh, E., Morgan, J., …
Lainhart, J. E. (2006). Comorbid psychiatric disorders in children with autism:
Interview development and rates of disorders. Journal of Autism and
Developmental Disorders, 36(7), 849–861. https://doi.org/10.1007/s10803-0060123-0
Manford, M. (2001). Assessment and Investigation of Possible Epileptic Seizures.
Journal of Neurology, Neurosurgery & Psychiatry, 70(suppl 2), ii3–ii8.
https://doi.org/10.1136/jnnp.70.suppl_2.ii3
Mannion, A., Leader, G., & Healy, O. (2013). An investigation of comorbid
psychological disorders, sleep problems, gastrointestinal symptoms and epilepsy
in children and adolescents with Autism Spectrum Disorder. Research in Autism
Spectrum Disorders, 7(1), 35–42. https://doi.org/10.1016/j.rasd.2012.05.002

47

Matson, J. L., Boisjoli, J., & Wilkins, J. (2007). The baby and infant screen for children
with aUtIsm traits (BISCUIT). Baton Rouge, LA: Disability Consultants, LLC.
Matson, J. L., & Kozlowski, A. M. (2011). The increasing prevalence of autism spectrum
disorders. Research in Autism Spectrum Disorders, 5(1), 418–425.
https://doi.org/10.1016/j.rasd.2010.06.004
Matson, J. L., & Neal, D. (2009). Seizures and epilepsy and their relationship to autism
spectrum disorders. Research in Autism Spectrum Disorders, 3(4), 999–1005.
https://doi.org/10.1016/j.rasd.2009.06.003
Matson, J. L., & Nebel-Schwalm, M. S. (2007). Comorbid psychopathology with autism
spectrum disorder in children: An overview. Research in Developmental
Disabilities, 28(4), 341–352. https://doi.org/10.1016/j.ridd.2005.12.004
Matson, J. L., Wilkins, J., & Fodstad, J. C. (2011). The validity of the Baby and Infant
Screen for Children with aUtIsm Traits: Part 1 (BISCUIT: Part 1). Journal of
Autism and Developmental Disorders, 41(9), 1139–1146.
https://doi.org/10.1007/s10803-010-0973-3
Matson, J. L., Wilkins, J., Sharp, B., Knight, C., Sevin, J. A., & Boisjoli, J. A. (2009).
Sensitivity and specificity of the Baby and Infant Screen for Children with aUtIsm
Traits (BISCUIT): Validity and cutoff scores for autism and PDD-NOS in
toddlers. Research in Autism Spectrum Disorders, 3(4), 924–930.
https://doi.org/10.1016/j.rasd.2009.04.001
Mazurek, M. O. (2016). The History of Comorbidity in Autism Spectrum Disorders
(ASD). In J. L. Matson (Ed.), Comorbid Conditions Among Children with Autism
Spectrum Disorders (pp. 3–25). Springer International Publishing. Retrieved from
http://link.springer.com/chapter/10.1007/978-3-319-19183-6_1
Mazurek, M. O., & Petroski, G. F. (2015). Sleep problems in children with autism
spectrum disorder: examining the contributions of sensory over-responsivity and
anxiety. Sleep Medicine, 16(2), 270–279.
https://doi.org/10.1016/j.sleep.2014.11.006
Mazurek, M. O., Vasa, R. A., Kalb, L. G., Kanne, S. M., Rosenberg, D., Keefer, A., …
Lowery, L. A. (2012). Anxiety, sensory over-responsivity, and gastrointestinal
problems in children with autism spectrum disorders. Journal of Abnormal Child
Psychology, 41(1), 165–176. https://doi.org/10.1007/s10802-012-9668-x
McCandless, D. W. (2012). Epilepsy, Animal and Human Correlations. New York, N.Y:
Springer Science + Business Media.
McGrother, C. W., Bhaumik, S., Thorp, C. F., Hauck, A., Branford, D., & Watson, J. M.
(2006). Epilepsy in adults with intellectual disabilities: Prevalence, associations

48

and service implications. Seizure, 15(6), 376–386.
https://doi.org/10.1016/j.seizure.2006.04.002
Meador, K. J. (2002). Cognitive outcomes and predictive factors in epilepsy. Neurology,
58(8 suppl 5), S21–S26. https://doi.org/10.1212/WNL.58.8_suppl_5.S21
Moss, J., & Howlin, P. (2009). Autism spectrum disorders in genetic syndromes:
implications for diagnosis, intervention and understanding the wider autism
spectrum disorder population. Journal of Intellectual Disability Research, 53(10),
852–873. https://doi.org/10.1111/j.1365-2788.2009.01197.x
Mouridsen, S. E., Rich, B., & Isager, T. (1999). Epilepsy in disintegrative psychosis and
infantile autism: a long-term validation study. Developmental Medicine & Child
Neurology, 41(2), 110–114.
Mouridsen, S. E., Rich, B., & Isager, T. (2011). A longitudinal study of epilepsy and
other central nervous system diseases in individuals with and without a history of
infantile autism. Brain and Development, 33(5), 361–366.
https://doi.org/10.1016/j.braindev.2010.07.002
Neal, E. G., Chaffe, H., Schwartz, R. H., Lawson, M. S., Edwards, N., Fitzsimmons, G.,
… Cross, J. H. (2008). The ketogenic diet for the treatment of childhood epilepsy:
a randomised controlled trial. The Lancet Neurology, 7(6), 500–506.
https://doi.org/10.1016/S1474-4422(08)70092-9
Newschaffer, C. J., Croen, L. A., Daniels, J., Giarelli, E., Grether, J. K., Levy, S. E., …
Windham, G. C. (2007). The epidemiology of autism spectrum disorders. Annual
Review of Public Health, 28(1), 235–258.
https://doi.org/10.1146/annurev.publhealth.28.021406.144007
Noachtar, S., & Rémi, J. (2009). The role of EEG in epilepsy: A critical review. Epilepsy
& Behavior, 15(1), 22–33. https://doi.org/10.1016/j.yebeh.2009.02.035
Nomura, Y., Nagao, Y., Kimura, K., Hachimori, K., & Segawa, M. (2010). Epilepsy in
autism: A pathophysiological consideration. Brain and Development, 32(10),
799–804. https://doi.org/10.1016/j.braindev.2010.08.001
O’Brien, D. (1998). Toxic and metabolic causes of seizures. Clinical Techniques in Small
Animal Practice, 13(3), 159–166. https://doi.org/10.1016/S1096-2867(98)800376
O’Leary, D. S., Seidenberg, M., Berent, S., & Boll, T. J. (1981). Effects of Age of Onset
of Tonic-Clonic Seizures on Neuropsychological Performance in Children.
Epilepsia, 22(2), 197–204. https://doi.org/10.1111/j.1528-1157.1981.tb04102.x

49

Peake, D., Notghi, L. M., & Philip, S. (2006). Management of epilepsy in children with
autism. Current Paediatrics, 16(7), 489–494.
https://doi.org/10.1016/j.cupe.2006.08.013
Reilly, C., Atkinson, P., Das, K. B., Chin, R. F. M. C., Aylett, S. E., Burch, V., …
Neville, B. G. R. (2014). Neurobehavioral Comorbidities in Children With Active
Epilepsy: A Population-Based Study. Pediatrics, 133(6), e1586–e1593.
https://doi.org/10.1542/peds.2013-3787
Reilly, C., & Gillberg, C. (2016). Epilepsy. In Johnny L. Matson (ed.) (Ed.), Comorbid
conditions in individuals with intellectual disabilities. Switzerland: Springer
International Publishing.
Rutter, M. (1968). Concepts of Autism: A Review of Research. Journal of Child
Psychology and Psychiatry, 9(1), 1–25. https://doi.org/10.1111/j.14697610.1968.tb02204.x
Rutter, M., & Schopler, E. (1987). Autism and pervasive developmental disorders:
Concepts and diagnostic issues. Journal of Autism and Developmental Disorders,
17(2), 159–186. https://doi.org/10.1007/BF01495054
Saemundsen, E., Ludvigsson, P., Hilmarsdottir, I., & Rafnsson, V. (2007). Autism
Spectrum Disorders in Children with Seizures in the First Year of Life—A
Population-Based Study. Epilepsia, 48(9), 1724–1730.
https://doi.org/10.1111/j.1528-1167.2007.01150.x
Shattuck, P. T., Durkin, M., Maenner, M., Newschaffer, C., Mandell, D. S., Wiggins, L.,
… Cuniff, C. (2009). Timing of identification among children with an autism
spectrum disorder: Findings from a population-based surveillance study. Journal
of the American Academy of Child & Adolescent Psychiatry, 48(5), 474–483.
https://doi.org/10.1097/CHI.0b013e31819b3848
Shorvon, S. D. (2011). The etiologic classification of epilepsy. Epilepsia, 52(6), 1052–
1057. https://doi.org/10.1111/j.1528-1167.2011.03041.x
Shubrata, K. S., Sinha, S., Seshadri, S. P., Girimaji, S., Subbakrishna, D. K., & Srinath,
S. (2014). Childhood Autism Spectrum Disorders With and Without Epilepsy
Clinical Implications. Journal of Child Neurology, 0883073814540521.
https://doi.org/10.1177/0883073814540521
Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., & Baird, G. (2008).
Psychiatric disorders in children with autism spectrum disorders: Prevalence,
comorbidity, and associated factors in a population-derived sample. Journal of the
American Academy of Child & Adolescent Psychiatry, 47(8), 921–929.
https://doi.org/10.1097/CHI.0b013e318179964f

50

Smeets, V. M. J., van Lierop, B. A. G., Vanhoutvin, J. P. G., Aldenkamp, A. P., &
Nijhuis, F. J. N. (2007). Epilepsy and employment: Literature review. Epilepsy &
Behavior, 10(3), 354–362. https://doi.org/10.1016/j.yebeh.2007.02.006
Smith, K. R. M., & Matson, J. L. (2010). Social skills: Differences among adults with
intellectual disabilities, co-morbid autism spectrum disorders and epilepsy.
Research in Developmental Disabilities, 31(6), 1366–1372.
https://doi.org/10.1016/j.ridd.2010.07.002
Tabachnick, B. G., & Fidell, L. S. (2007). Using multivariate statistics. Boston:
Pearson/Allyn & Bacon.
Tarulli, A. (2016). Seizures and Epilepsy. In A. Tarulli (Ed.), Neurology: A Clinician’s
Approach (2nd ed.). Switzerland: Springer International Publishing.
Tidmarsh, L., & Volkmar, F. R. (2003). Diagnosis and epidemiology of autism spectrum
disorders. Canadian Journal of Psychiatry, 48(8), 517.
Tuchman, R., Alessandri, M., & Cuccaro, M. (2010). Autism spectrum disorders and
epilepsy: Moving towards a comprehensive approach to treatment. Brain and
Development, 32(9), 719–730. https://doi.org/10.1016/j.braindev.2010.05.007
Tuchman, R. F., & Rapin, I. (1997). Regression in Pervasive Developmental Disorders:
Seizures and Epileptiform Electroencephalogram Correlates. Pediatrics, 99(4),
560–566. https://doi.org/10.1542/peds.99.4.560
Tuchman, R., & Rapin, I. (2002). Epilepsy in autism. The Lancet Neurology, 1(6), 352–
358. https://doi.org/10.1016/S1474-4422(02)00160-6
Vasconcellos, E., Wyllie, E., Sullivan, S., Stanford, L., Bulacio, J., Kotagal, P., &
Bingaman, W. (2001). Mental Retardation in Pediatric Candidates for Epilepsy
Surgery: The Role of Early Seizure Onset. Epilepsia, 42(2), 268–274.
https://doi.org/10.1046/j.1528-1157.2001.12200.x
Vingerhoets, G. (2006). Cognitive effects of seizures. Seizure, 15(4), 221–226.
https://doi.org/10.1016/j.seizure.2006.02.012
Viscidi, E. W., Johnson, A. L., Spence, S. J., Buka, S. L., Morrow, E. M., & Triche, E.
W. (2013). The association between epilepsy and autism symptoms and
maladaptive behaviors in children with autism spectrum disorder. Autism,
1362361313508027.
Volkmar, F. R., Lord, C., Bailey, A., Schultz, R. T., & Klin, A. (2004). Autism and
pervasive developmental disorders. Journal of Child Psychology and Psychiatry,
45(1), 135–170. https://doi.org/10.1046/j.0021-9630.2003.00317.x

51

Volkmar, F. R., & Reichow, B. (2013). Autism in DSM-5: progress and challenges.
Molecular Autism, 4, 13. https://doi.org/10.1186/2040-2392-4-13

52

Vita
Claire Olivia Burns was born in Westchester, New York and attended Tulane University
in New Orleans from August 2010 to May 2014 where she earned a Bachelor of Science
in psychology. Claire is a second-year graduate student in clinical psychology at
Louisiana State University in Baton Rouge, Louisiana, under the supervision of Dr.
Johnny L. Matson. Claire’s clinical and research interests include early identification and
intervention of autisms spectrum disorder and developmental disorders, with particular
emphasis on social cognition and cultural considerations.

53

